530.20
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDEXX Laboratories, Inc. (IDXX) Stock Price, News, Quote & History - Yahoo! Finance Canada
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories stock falls 1.65 percent below USD 747 target - AD HOC NEWS
IDEXX Laboratories stock heads into the open after September 24 update - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IDEXX Laboratories, Inc. (IDXX) stock price, news, quote and history - Yahoo Finance Singapore
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo! Finance Canada
Should You Continue to Hold IDXX Stock in Your Portfolio? - TradingView
IDEXX Laboratories stock gains as revenue outlook meets premium valuation - AD HOC NEWS
IDEXX Laboratories stock heads into the open after a 1.16 percent gain - AD HOC NEWS
IDEXX Laboratories Acquires CoVetAI to Enhance Veterinary Software Ecosystem - Global Legal Chronicle
IDEXX Laboratories stock gains 1.16 percent as valuation holds - ad-hoc-news.de
IDEXX Laboratories stock heads into the open after recent gains - AD HOC NEWS
IDEXX Laboratories stock gains after double digit Q2 growth and raised guidance - AD HOC NEWS
Recent acquisitions: IDEXX buys CoVet, The Farmer's Dog acquires Woof - DVM360
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets - Yahoo Finance
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference - Yahoo Finance
IDEXX Laboratories stock gains attention after CoVetAI deal and Stifel Buy rating - AD HOC NEWS
IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics - Yahoo Finance
IDEXX Laboratories Inc | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
IDEXX Laboratories stock holds after Stifel keeps Buy rating - AD HOC NEWS
Why Is the Market Reassessing IDEXX Laboratories (IDXX)? - Kalkine Media
IDEXX Laboratories stock holds Stifel Buy rating after Q2 earnings beat - ad-hoc-news.de
Stifel reiterates Buy on IDEXX Laboratories stock citing vet survey By Investing.com - Investing.com Australia
IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide - Yahoo Finance
IDEXX Laboratories stock heads into the open after a modest pullback - AD HOC NEWS
IDEXX Laboratories (IDXX) Could Be 29% Below Fair Value As Diagnostics Growth Stays In Focus - Yahoo Finance
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence - Vet Candy
IDEXX Laboratories stock gains as CoVetAI deal and new parasite tests bolster growth narrative - AD HOC NEWS
IDEXX Stock Gains Following the Acquisition of CoVet - Yahoo Finance
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection - PA Media
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $670 - moomoo.com
IDEXX Laboratories (IDXX) Looks 19.8% Undervalued on GF Value™ - GuruFocus
IDEXX Laboratories Acquires Veterinary AI Software Firm CoVetAI - marketscreener.com
Press Release: IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence - Moomoo
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 38% Potential Upside For Investors - DirectorsTalk Interviews
IDXX - Finviz
IDEXX Laboratories stock gains as analysts lift targets - ad-hoc-news.de
IDEXX Laboratories stock reacts to insider share sale and recent earnings strength - ad-hoc-news.de
Engaging In Options Activity, Lawrence D Kingsley Exercises Options Valued At $873K In IDEXX Laboratories - Benzinga
Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock - The Motley Fool
Is IDEXX Laboratories Stock Underperforming the Dow? - inkl
Idexx Laboratories stock hits 52-week low at $517.00 By Investing.com - Investing.com Australia
IDEXX Laboratories (IDXX) director exercises options and sells 2,203 shares - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):